Search

Your search keyword '"Faivre-Finn, C"' showing total 1,472 results

Search Constraints

Start Over You searched for: Author "Faivre-Finn, C" Remove constraint Author: "Faivre-Finn, C"
1,472 results on '"Faivre-Finn, C"'

Search Results

55. EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)

56. EP08.03-005 HALT - Targeted Therapy with or without Dose-Intensified Radiotherapy in Oligo-Progressive Disease in Oncogene Addicted Lung Tumours

57. EP05.01-012 Avoiding Cardiac Toxicity in Lung Cancer Radiotherapy (ACcoLade) Trial - Initial Results

60. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

65. Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study

70. OC-0437 Impact of introducing IMRT on curative intent radiotherapy and survival for lung cancer

76. PO-1877 Initial experience delivering stereotactic radiotherapy to a gluteal metastasis on a 1.5T MR Linac

79. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

81. Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study

82. Targeting PARP for Chemoradiosensitization: Opportunities, Challenges, and the Road Ahead

83. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

84. Exercise in lung Cancer, the healthcare providers opinion (ECHO): Results of the EORTC lung cancer Group (LCG) survey

86. 108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

88. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

89. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

90. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

91. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

94. Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib vs. Concurrent Chemoradiation Therapy in Patients With Newly Diagnosed Limited-Stage Small-Cell Lung Cancer: KEYLYNK-013

98. 1170O An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Characterisation of PORT efficacy in lung ART (IFCT-0503, UK NCRI, SAKK)

Catalog

Books, media, physical & digital resources